'I believe most of us understand the significant upside opportunity presented by SRX's large randomised controlled trials, but I haven't seen any discussion of their trial of sir-spheres in kidney cancer. See http://www.anzctr.org.au/TrialSearch.aspx'
Last time I saw any data the recruitment was so far behind schedule it was disappointing to say the least. Europe is Theraspheres playground and I think SRX are having a very hard time there - IMO
roger montgomery - the australian, page-5
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.003(1.41%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $11.32K | 63.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6835717 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1404477 | 13 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |